PanGenomic Health, Inc. Class A (TSE:NARA) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
PanGenomic Health, Inc. has applied for a management cease trade order due to delays in filing its audited financial statements, attributed to outstanding payments owed to its auditors. The company is seeking financing solutions and anticipates resolving the issue by June 29, 2024. In the meantime, trading by the general public in the company’s securities remains unaffected, while the CEO and CFO are prohibited from trading until the filings are completed.
For further insights into TSE:NARA stock, check out TipRanks’ Stock Analysis page.
